Psychiatry News CME

• Diclofenac Liquid-Filled Capsules Approved for Pain Relief CME/CE The FDA has approved diclofenac potassium liquid-filled soft gelatin capsules for the relief of mild to moderate acute pain in patients aged 18 years and older.
  Medscape Medical News CME, July 2009
• Cancer Risk in Schizophrenia Needs More Attention CME/CE People with schizophrenia are 50% more likely to die of cancer than people in the general population.
  Medscape Medical News CME, June 2009
• EUFEST: First- and Second-Generation Antipsychotics Equal in Improving Cognition in Schizophrenia CME The European First Episode Schizophrenia Trial shows low-dose haloperidol is as good as other agents.
  Medscape Medical News CME, June 2009
• FDA Safety Changes: Kerlone, Meridia, Stromectol CME/CE The FDA has approved safety labeling revisions for betaxolol HCl tablets (Kerlone), sibutramine HCl monohydrate capsules (Meridia), and ivermectin tablets (Stromectol).
  Medscape Medical News CME, June 2009
• Improved Fetal Growth May Predict Increased IQ at School Age CME A study shows that longer birth length, higher birth weight, or larger head circumferences within the normal range are linked to higher IQ scores in Asian children.
  Medscape Medical News CME, June 2009
• New Test May Detect Early Alzheimer's Disease CME he cognitive test is quick to use, examines 10 skills, and reportedly detects 93% of cases of Alzheimer's disease.
  Medscape Medical News CME, June 2009
• FDA Safety Changes: Sarafem, Mavik, Cordarone CME/CE The FDA has approved safety labeling revisions for deferasirox tablets for fluoxetine HCl (Sarafem tablets), trandolapril (Mavik tablets), and amiodarone HCl (Cordarone tablets).
  Medscape Medical News CME, June 2009
• Depression, Musculoskeletal Pain May Respond to Antidepressant Therapy, Pain Self-Management CME Depression, Pain Respond to Antidepressant Therapy, Pain Self-Management
  Medscape Medical News CME, June 2009
• Alzheimer's and MCI Shorten Survival in Both Blacks and Whites CME When it comes to race, Alzheimer's disease and mild cognitive impairment do not discriminate--both are associated with a similarly increased risk for death in elderly black and white patients.
  Medscape Medical News CME, June 2009
• Screening at 2 Months Identifies Most Women With Postpartum Depression CME/CE Using a well-child visit to screen for postpartum depression 2 months after delivery will catch the majority of women likely to develop the condition within the first 6 postpartum months.
  Medscape Medical News CME, June 2009
• Sedatives and Hypnotics May Increase Risk for Suicide in Elderly Patients CME A study shows that sedatives and hypnotics are associated with an increased risk for suicide in elderly patients, mandating evaluation of suicide risk before prescribing such drugs.
  Medscape Medical News CME, June 2009
• Cognitive Behavior Program Reduces Depression in High Risk Adolescents CME Intervention could have a significant impact on preventing youth depression.
  Medscape Medical News CME, June 2009
• Web- and Computer-Based Smoking Cessation Programs May Be Effective for Adult Smokers CME/CE A meta-analysis of randomized controlled trials suggests that sufficient clinical evidence supports the use of Web-based and computer-based smoking cessation programs for adult smokers.
  Medscape Medical News CME, June 2009
• Citalopram Ineffective for Treatment of Repetitive Behaviors in Children With Autism CME The selective serotonin reuptake inhibitor citalopram appears to be no more effective than placebo at reducing repetitive behaviors in children with autism spectrum disorders.
  Medscape Medical News CME, June 2009
• Vitamin D Status Linked to Cognitive Function in Older Men CME A study shows that lower 25-hydroxyvitamin D levels are associated with slower psychomotor processing speed as indicated by poor performance on the Digit Symbol Substitution Test.
  Medscape Medical News, June 2009
• Violence in Schizophrenia Rare in the Absence of Substance Abuse CME The increased risk of violent crime associated with schizophrenia is largely due to the subgroup of patients who are also substance abusers, according to a new study.
  Medscape Medical News, June 2009
• FDA Safety Changes: Advair Diskus, Orap, Rocephin CME/CE The FDA has approved safety labeling revisions for fluticasone propionate and salmeterol xinafoate inhalation powder, pimozide tablets, and ceftriaxone sodium injection.
  Medscape Medical News, May 2009
• FDA Approvals: Risperdal Consta and Cimzia CME/CE The FDA has approved new indications for risperidone long-acting injection (Risperdal Consta) and certolizumab pegol (Cimzia).
  Medscape Medical News, May 2009
• Taper Medication, Continue Behavioral Therapy Best Long-Term Approach for Chronic Insomnia CME The first head-to-head comparison of treatment approaches to determine separate and combined effects on insomnia shows initial combination therapy, followed by tapering medication and continuing with CBT alone, produces the best long-term outcome.
  Medscape Medical News, May 2009
• FDA Approves Lamictal Orally Disintegrating Tablets for Bipolar Disorder, Epilepsy CME/CE Lamotrigine orally disintegrating tablets have been approved by the FDA for maintenance treatment of bipolar 1 disorder acute mood episodes and as an antiseizure treatment of epilepsy.
  Medscape Medical News, May 2009